CoChat

Inflammation as a Sensor of Metabolic Stress in Obesity and Type 2 Diabetes

Donath, Marc Y. · 2011 · Endocrinology
Cited by 41

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

It is broadly accepted that the main cause of type 2 diabetes is overfeeding. Unclear is how this metabolic stress is translated into signals leading to defective insulin secretion and action. Increasing evidence points to a role of the innate immune system in sensing changes in nutrient levels. This results in an inflammatory process that has been proposed to contribute to the pathogenesis of type 2 diabetes (1). At the origin of this process, activation of the IL-1 pathway seems to play a central role. Processing of pro-IL-1β to IL-1β is controlled by the inflammasome (see below) as a response to sensing danger signals. In this issue of Endocrinology, Youm and colleagues (2) demonstrates that the inflammasome mediates islet inflammation induced by high-fat feeding. Activation of the innate immune system is the first response to tissue injury or aggression. It is characterized by release of cytokines and chemokines and immune cell invasion and is accompanied by functional or structural damage followed by tissue repair or fibrosis. This inflammatory process was originally thought to be caused by microbes or physical damages. However, in some cases, the innate immune system may attack the body's own tissues in the absence of an exogenous aggressor, resulting in a sterile inflammatory process, i.e. an autoinflammatory disease. In the pancreatic islet, metabolic stress may also elicit such a response. Indeed, glucose, free fatty acids, and human islet amyloid polypeptide may induce IL-1β, launching a proinflammatory response impairing insulin production and secretion (3–6). Accordingly, blocking IL-1β improves insulin release and glycemia in prediabetic and diabetic patients (7, 8). The question arises of how metabolic stress is sensed by the IL-1 system. The inflammasome is a key factor mediating activation of innate immunity. It is a complex of several proteins that may activate caspase 1, which cleaves pro-IL-1β to IL-1β. Activation of IL-1β will then induce itself and a variety of cytokines and chemokines via nuclear factor-κB. Interestingly, the inflammasome can be activated by a variety of metabolic disturbance including uric acid during gout arthritis (9) and cholesterol in atherogenesis (10). In the context of diabetes, it has been shown that glucose and human islet amyloid polypeptide activates the inflammasome in pancreatic islets (5, 6, 11) and lipopolysaccharide, free fatty acids, and ceramides in adipose tissues (12–14). All of this assigns to the inflammasome a role as a sensor of metabolic stress. The above mentioned studies have convincingly shown the functional role of the inflammasome in insulin resistance (12–14). With respect to islet inflammation, animal and clinical studies have shown that reducing IL-1β activity improves insulin secretion (7, 8, 15, 16). However, it remained to be demonstrated that this involves the inflammasome. In the study by Youm and colleagues (2), it is shown that lack of the NLRP3 inflammasome protects from the development of islet fibrosis in mice on a high-fat diet. Because fibrosis is an end stage of a chronic inflammatory process, it may be assumed that the level of insulitis was decreased, although data on immune cell infiltration are missing in this study. Another weakness of the study is the lack of functional insulin secretion tests. However, islet mass and insulin release were improved in the NLRP3 knockout mice on a high-fat diet compared with wild-type controls. Therefore, it can be concluded that inflammasome is most probably a critical mediator of islet inflammation in obesity. Thus, unraveling the molecular mechanisms underlying induction of an inflammatory response during obesity and diabetes assigns to the innate immune system a new role in detecting metabolic dangers. The inflammasome appears as the sentinel sensing metabolic stress and alarming the immune defense in pancreatic islets, insulin-sensitive tissues, and blood vessels. It is likely that this inflammatory process has protective effects, but eventually, chronic inflammation will become deleterious. Future studies should aim at understanding in more detail this process to develop treatment modalities allowing a targeted use of antiinflammatory drugs such as IL-1β blockers and salsalate (7, 17). Disclosure Summary: The author has nothing to disclose.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2011-1691

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 41

Metadata

Authors
Donath, M. Y.
Venue
Endocrinology
Published
2011-11-01
Volume
152
Issue
11
Pages
4005-4006
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2112637644
Cited by
41
References
2
FWCI
1.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.